Catalyst Wire Dossier Catalyst Wire Dossier

candesartan-amlodipine combination therapy

· Chong Kun Dang Pharmaceutical
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for candesartan-amlodipine combination therapy, covering 2020-08-25 to 2020-08-25. Get the full timeline:

Most recent: Clinical Trial Update: Trial to Evaluate the Efficacy and Safety of a Combination Therapy of Candesartan and Amlodipine Versus Candesartan Monotherapy in Hypertensive Patients Inadequately Controlled by Candesartan Monotherapy [Phase 3]

See pricing